Anna Bonjoch
- Infectious Diseases top 1%
- Virology top 0.5%
- Emergency Medicine top 0.5%
- Epidemiology top 10%
- Orthopedics and Sports Medicine top 5%
- Co-authors
- Bonaventura ClotetEugènia NegredoJoan RomeuRoger ParedesJordi PuigNúria Pérez‐ÁlvarezCarmina R. FumazLı́dia Ruiz
- Topics
- HIV/AIDS drug development and treatment (45 papers)HIV Research and Treatment (38 papers)HIV-related health complications and treatments (36 papers)
- Partner nations
- SpainUnited StatesNetherlands
In The Last Decade
Anna Bonjoch
62 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 90
- Infectious Diseases 1.3k
- Virology 973
- Emergency Medicine 821
- Epidemiology 337
- Orthopedics and Sports Medicine 174
Countries citing papers authored by Anna Bonjoch
This map shows the geographic impact of Anna Bonjoch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Bonjoch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Bonjoch more than expected).
Fields of papers citing papers by Anna Bonjoch
This network shows the impact of papers produced by Anna Bonjoch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Bonjoch. The network helps show where Anna Bonjoch may publish in the future.
Co-authorship network of co-authors of Anna Bonjoch
This figure shows the co-authorship network connecting the top 25 collaborators of Anna Bonjoch. A scholar is included among the top collaborators of Anna Bonjoch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Bonjoch. Anna Bonjoch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 10 | |
| 3 | 15 | |
| 4 | 9 | |
| 5 | 17 | |
| 6 | 1 | |
| 7 | 10 | |
| 8 | 24 | |
| 9 | 25 | |
| 10 | 36 | |
| 11 | 11 | |
| 12 | 5 | |
| 13 | 28 | |
| 14 | 39 | |
| 15 | 17 | |
| 16 | 27 | |
| 17 | 112 | |
| 18 | 197 | |
| 19 | Cumulative risk for developing hyperlipidemia in HIV-infected patients treated with protease inhibitors | 11 |
| 20 | 20 |
About Anna Bonjoch
Anna Bonjoch is a scholar working on Virology, Emergency Medicine and Infectious Diseases, having authored 63 papers that have together received 1.9k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (45 papers), HIV Research and Treatment (38 papers) and HIV-related health complications and treatments (36 papers). The work is most often cited by research in Virology (973 citations), Emergency Medicine (821 citations) and Infectious Diseases (1.3k citations). Anna Bonjoch has collaborated with scholars based in Spain, United States and Netherlands. Frequent co-authors include Bonaventura Clotet, Eugènia Negredo, Joan Romeu, Roger Paredes, Jordi Puig, Núria Pérez‐Álvarez, Carmina R. Fumaz, Lı́dia Ruiz, Antoni Jou and Patricia Echeverría. Their work appears in journals such as PLoS ONE, Clinical Infectious Diseases and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.